Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.560
-0.090 (-5.45%)
At close: Nov 20, 2024, 4:00 PM
1.600
+0.040 (2.56%)
Pre-market: Nov 21, 2024, 7:00 AM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $124.37 million as of November 21, 2024. Its market cap has increased by 128.26% in one year.
Market Cap
124.37M
Enterprise Value
113.15M
1-Year Change
128.26%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from $69.77M to $124.37M, an increase of 78.27%. That is a compound annual growth rate of 10.26%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Pro-Dex | 147.35M |
PepGen | 145.70M |
Black Diamond Therapeutics | 144.29M |
Acumen Pharmaceuticals | 143.59M |
Elutia | 143.39M |
Vaxart | 141.01M |
Sagimet Biosciences | 140.74M |
Sensus Healthcare | 137.09M |